Get access to our best features
Get access to our best features
Published 1 year ago

Six Additional Weeks of Rivaroxaban Reduces Recurrent VTE

Summary by Ground News
Six additional weeks of rivaroxaban reduces risk for recurrent venous thromboembolism. In 40 and 43 percent of patients, isolated distal DVT was unprovoked. Proximal DVT or pulmonary embolism occurred in 3 and 4% of patients.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)